Who Should Use Penile Traction Therapy | SizeGenetics

If you're wondering whether penile traction therapy is actually meant for you, that's the right question to ask before you ever think about results. Because this isn't a gadget for curiosity or impulse. Penile traction therapy is a medical approach, and the men who benefit most are the ones who fit clear clinical criteria and commit to using it properly.

The strongest evidence points to three main groups. First, men with chronic-phase Peyronie's disease. Second, men recovering from prostate surgery as part of penile rehabilitation. Third, men with medically assessed penile length concerns who have been properly evaluated by a healthcare provider. Those aren't marketing categories. They're the patient groups that appear again and again in the clinical literature.

A 2023 systematic review and meta-analysis by Almsaoud, Safar, and Alshahrani, published in Translational Andrology and Urology, pooled twelve clinical studies involving more than 1,000 patients. That analysis found a mean length gain of 1.9 centimeters, about 0.75 inches, along with a 27 percent mean improvement in curvature in appropriate Peyronie's disease cases. That's important, because it tells us candidacy isn't guesswork. There are patterns in who tends to benefit.

For men with Peyronie's disease, timing matters. Penile traction therapy is generally used in the chronic, stable phase, not during the acute inflammatory stage when pain and active changes are still happening. Studies such as Gontero et al. in 2009 and Levine et al. in 2008 helped establish traction as a meaningful non-surgical option for men with stable curvature and associated length loss. In practical terms, that means a man with established Peyronie's disease, no active pain, and a clear treatment plan from a urologist may be a strong candidate.

Post-prostatectomy patients are another important group. After surgery, preserving penile length and supporting erectile rehabilitation can be a real concern. In the randomized controlled trial by Toussi and colleagues, published in The Journal of Urology in 2021, men using traction achieved a 1.6 centimeter gain versus 0.3 centimeters in controls, with strong satisfaction signals, including 93 percent saying they would recommend the therapy. For the right patient, under medical supervision, traction can play a useful role in recovery.

What about men simply worried about size? This is where medical judgment becomes essential. Some men have objectively documented issues, including micropenis or significant shortening after disease or surgery. Others have normal anatomy but high anxiety or unrealistic expectations. A responsible clinician should separate those two groups carefully. Penile traction therapy may be appropriate when there is a real medical indication, but it should never replace honest evaluation, realistic counseling, and, when needed, psychological support.

Age matters too. Penile traction therapy is for adults with completed physical development. In practice, that means age 18 and older, with most studies enrolling men roughly between 25 and 45. Older men may still be candidates, but they often need closer monitoring, especially if vascular disease, diabetes, or slower tissue healing are part of the picture. The therapy can still be relevant, but the protocol may need adjustment.

Just as important is knowing who should not use penile traction therapy. Men with active urogenital infections, uncontrolled bleeding disorders, severe cardiovascular instability, or recent genital surgery generally should not begin traction until medically cleared. Men in the painful acute phase of Peyronie's disease are not ideal candidates either. And there's one more exclusion that doesn't get enough attention: poor adherence. If someone cannot realistically commit to four to six hours a day for three to six months, the likelihood of meaningful clinical outcomes drops fast.

That commitment piece matters because traction works through mechanotransduction, the cellular response to mechanical force. In plain language, the tissue needs consistent, repeated therapeutic tension over time. That's why proper devices, proper instruction, and realistic follow-through matter so much more than hype. When a man is a good candidate, follows protocol, and uses a legitimate medical device, the evidence shows penile traction therapy can be well tolerated. Across the clinical literature, adverse events have generally been mild and temporary, in the range of 11.2 to 14.4 percent, with no serious adverse events reported.

So who should use penile traction therapy? Men with a medically appropriate reason, no major contraindications, and the willingness to treat it like a real therapy, not a shortcut. If that sounds like you, the smartest next step isn't guessing online. It's talking with a qualified urologist, getting a proper evaluation, and understanding whether a structured penile traction protocol with an FDA-registered medical device like SizeGenetics fits your situation. The goal isn't just to start treatment. The goal is to start the right treatment, for the right patient, in the right way.